UMIN-CTR Clinical Trial

BACK TOP
UMIN-CTR English Home Glossary (Simple) FAQ Search clinical trials

Name:
UMIN ID:

Recruitment status Completed
Unique ID issued by UMIN UMIN000009303
Receipt No. R000010925
Scientific Title A prospective multicenter study that will contribute to the policy recommendations of cancer treatment and palliative treatment surrounding the young cancer patients
Date of disclosure of the study information 2012/11/10
Last modified on 2013/11/10

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information
Public title A prospective multicenter study that will contribute to the policy recommendations of cancer treatment and palliative treatment surrounding the young cancer patients
Acronym A study of the young cancer patients
Scientific Title A prospective multicenter study that will contribute to the policy recommendations of cancer treatment and palliative treatment surrounding the young cancer patients
Scientific Title:Acronym A study of the young cancer patients
Region
Japan

Condition
Condition Solid tumor
Classification by specialty
Hematology and clinical oncology
Classification by malignancy Malignancy
Genomic information NO

Objectives
Narrative objectives1 In order to better the quality of medical care and end-of-life care and welfare services to be provided to young cancer patients, we examine the background of patients, families and social, and investigate the actual situation and needs of cancer care, palliative care and welfare services
Basic objectives2 Others
Basic objectives -Others Observation study
Trial characteristics_1 Exploratory
Trial characteristics_2
Developmental phase Not applicable

Assessment
Primary outcomes Examine the background of patients, families and social, and investigate the actual situation and needs of cancer care, palliative care and welfare services with young cancer patients
Key secondary outcomes

Base
Study type Observational

Study design
Basic design
Randomization
Randomization unit
Blinding
Control
Stratification
Dynamic allocation
Institution consideration
Blocking
Concealment

Intervention
No. of arms
Purpose of intervention
Type of intervention
Interventions/Control_1
Interventions/Control_2
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10

Eligibility
Age-lower limit
20 years-old <=
Age-upper limit

Not applicable
Gender Male and Female
Key inclusion criteria 1)Patients who have solid tumor
2)Patients who are over 20 years of age
3)Patients who have given written informed consent
Key exclusion criteria Not eligible judged by physicians
Target sample size 50

Research contact person
Last name of lead principal investigator
1st name
Middle name
Last name Kan Yonemori
Organization National Cancer Center Hospital
Division name Breast and Medical Oncology div.
Zip code
Address 5-1-1 Tsukiji, Chuo-ku, Tokyo 104-0045, Japan
TEL 03-3542-2511
Email kyonemor@ncc.go.jp

Public contact
1st name of contact person
1st name
Middle name
Last name Eriko Nara
Organization National Cancer Center Hospital
Division name st and Medical Oncology div.
Zip code
Address 5-1-1 Tsukiji, Chuo-ku, Tokyo 104-0045, Japan
TEL 03-3542-2511
Homepage URL
Email enara@ncc.go.jp

Sponsor
Institute National Cancer Center Hospital
Institute
Department

Funding Source
Organization ministory of health, labour and welfare
Organization
Division
Category of Funding Organization
Nationality of Funding Organization

Other related organizations
Co-sponsor
Name of secondary funder(s)

IRB Contact (For public release)
Organization
Address
Tel
Email

Secondary IDs
Secondary IDs NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW

Institutions
Institutions

Other administrative information
Date of disclosure of the study information
2012 Year 11 Month 10 Day

Related information
URL releasing protocol
Publication of results Unpublished

Result
URL related to results and publications
Number of participants that the trial has enrolled
Results
Results date posted
Results Delayed
Results Delay Reason
Date of the first journal publication of results
Baseline Characteristics
Participant flow
Adverse events
Outcome measures
Plan to share IPD
IPD sharing Plan description

Progress
Recruitment status Completed
Date of protocol fixation
2012 Year 11 Month 30 Day
Date of IRB
Anticipated trial start date
2012 Year 12 Month 01 Day
Last follow-up date
Date of closure to data entry
Date trial data considered complete
Date analysis concluded

Other
Other related information Conduct research and analysis on background of cancer patients, families and social, and investigate the actual situation or needs of cancer care, palliative care and welfare services

Management information
Registered date
2012 Year 11 Month 10 Day
Last modified on
2013 Year 11 Month 10 Day


Link to view the page
URL(English) https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000010925

Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name


Contact us.